U.S.
stocks rose amid corporate dealmaking, while European equities advanced
and the euro weakened to an 11-year low as the region’s central bank
unveiled details of its debt-purchase plan.
The
Standard & Poor’s 500 Index advanced 0.2 percent at 12:13 p.m. in
New York, halting a two-day slide. Pharmacyclics Inc. surged 11 percent
after AbbVie Inc. agreed to buy the drugmaker in a $21 billion deal. The
Stoxx Europe 600 Index added 0.8 percent. The euro depreciated below
$1.10 for the first time since September 2003. Portugal’s 10-year yield
declined nine basis points to 1.79 percent. Treasuries were little
changed amid mixed U.S. economic data. Chinese equities slid as Asia’s
biggest economy cut its growth target.
The
ECB raised its outlook for growth 2016 and President Mario Draghi
committed to begin asset purchases next week that will amount to 60
billion euros ($66 billion) a month as the central bank institutes
quantitative easing to choke off the threat of deflation. U.S. data
showed the number of Americans filing for unemployment benefits rose to
the highest level in nine months before a government jobs report Friday.
Source : Bloomberg
0 komentar :
Post a Comment